The Conundrum of Giglio Island: Unraveling the dynamics of an apparent resistance to COVID-19 - A descriptive study.
COVID-19
Giglio Island
SARS-CoV-2
Journal
Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
01
2021
revised:
05
02
2021
accepted:
15
02
2021
pubmed:
9
3
2021
medline:
9
3
2021
entrez:
8
3
2021
Statut:
ppublish
Résumé
Despite an extensive risk of exposure to COVID-19, the residents of Giglio Island, Italy, did not develop any symptom of SARS-CoV-2. The present study aims to characterize the nature of exposure and to describe the local population dynamics underlying its apparent resistance to COVID-19. Descriptive study of an islander partially-segregated population cohort based on a seroprevalence screening conducted from Aprile 29 to May 3, 2020 and including SARS-CoV-2 seroprevalence and viral prevalence in samples of saliva assessed through RT-qPCR. Serologic testing was performed using a COVID-19 IgG/IgM rapid test while molecular analyses were carried out by Allplex 2019-nCoV Assay (Seegene). A total of 634 residents out of 748 (84.8%) present at the time, and 89 non-residents underwent serological testing. 364 males and 359 females with a median age of 58.5 years. The serological screening identified one positive, asymptomatic subject. The Nucleic Acid Amplification Tests (NAAT) did not yield any positive result. Despite extensive exposure to SARS-CoV-2, possibly only one new asymptomatic infection occurred in this population, as documented by IgM positivity not confirmed by RT-qPCR. This may be due to unknown protective factors or chance. On the basis of this baseline study, using its population as a reference model, further investigations will be conducted to test the advanced hypotheses, focusing on the evaluation of a possible cross-reactivity to SARS-CoV-2 from exposure to endemic viruses.
Identifiants
pubmed: 33680349
doi: 10.1016/j.csbj.2021.02.008
pii: S2001-0370(21)00059-3
pmc: PMC7920805
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1467-1471Informations de copyright
© 2021 The Authors.
Références
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Sci Total Environ. 2020 Jul 20;727:138704
pubmed: 32315904
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
N Engl J Med. 2003 May 15;348(20):1953-66
pubmed: 12690092
Clin Infect Dis. 2021 May 4;72(9):e352-e356
pubmed: 32761244
Lancet Glob Health. 2021 May;9(5):e598-e609
pubmed: 33705690
Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4
pubmed: 32422408
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Environ Pollut. 2020 Jun;261:114465
pubmed: 32268945
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Infect Ecol Epidemiol. 2020 Apr 14;10(1):1754538
pubmed: 32363011
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Clin Infect Dis. 2021 Mar 15;72(6):1064-1066
pubmed: 32584972
Bull Natl Res Cent. 2020;44(1):138
pubmed: 32843835